Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Antiserum, Positive Control, Blastomyces Dermatitidis

FDA product code KFH · 4 cleared devices

Class 2 Microbiology
Regulation
21 CFR 866.3060
Review panel
MI
Implant
No
Life sustaining
No
Third party review
No
GMP exempt
No
Clearance span
1976-11-01 – 1988-02-24
↑